CONTEXTVISION AB [CBOE] overview

The shareholders of ContextVision AB, corporate registration number 556377-8900, are hereby invited to attend an extraordinary general meeting on the 10 December, 2021 at 10 a.m CET at ContextVision AB's office, Klara Norra Kyrkogata 31, 111 22, Stockholm. Right to participate and notification Shareholders who wish to participate in the annual general meeting with the right to vote shall be entered in the share register kept by Euroclear Sweden AB as of Thursday, 2 December 2021, and give notice...

STOCKHOLM – Nov 15, 2021 - ContextVision, a medical technology software company specializing in image processing and decision support tools within digital pathology, today announces that the Board of Directors of ContextVision has decided to make a strategic shift and focus its pathology business unit entirely on the establishment of an AI based pathology lab service. The updated strategy means that the company will continue to develop its machine learning technology for its own laboratory...

STOCKHOLM – October 22, 2021 – Fredrik Palm, CEO of ContextVision, has on October 22 nd , 2021 purchased 2,500 shares in ContextVision AB at an average price of NOK 22.47 per share. After the transaction, Mr Palm holds a total of 30,700 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock ticker: CONTX Name...

STOCKHOLM – October 21, 2021 – Martin Ingvar, Member of the Board of ContextVision, has on October 21, 2021 purchased 6,000 shares in ContextVision AB at an average price of NOK 22.10 per share. After the transaction, Mr Ingvar holds a total of 12,000 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock...

STOCKHOLM – October 21, 2021 – ContextVision, a medical technology software company specializing in image processing and decision support tools within digital pathology, has decided to build its first fully digital pathology laboratory – thus confirming its strong dedication to advancing digitalization within pathology, for the best of both patients and the medical profession. Sales in the third quarter reached 26.0 MSEK (22.0), a 7% increase compared with the previous quarter, and an...

STOCKHOLM – October 18, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that results from a US clinical evaluation were presented at the Pathology Visions Congress in Las Vegas, USA. The evaluation was performed together with two independent pathologists, Anil Parwani, M.D., Ph.D., M.B.A. at Ohio State University Comprehensive Cancer Center (Columbus, Ohio), and Ming...

STOCKHOLM – September 1, 2021 – Martin Ingvar, Member of the Board of ContextVision, has on September 1, 2021 purchased 6,000 shares in ContextVision AB at an average price of NOK 24.41 per share. After the transaction, Mr Ingvar holds a total of 6,000 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction: Name of listed entity: ContextVision AB ISIN number: SE0014731154 Stock...

STOCKHOLM – August 31, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that results from FirstPath – a European multicenter clinical study evaluating performance of INIFY ® Prostate in routine clinical practice – were presented at the European Congress of Pathology by Dr. Jordi Temprana Salvador from Vall d’Hebron in Barcelona. The study was performed at four...